Secondary glaucoma after intravitreal dexamethasone implant in patients with retinal disorder.
作者信息
Mansoori Tarannum
机构信息
Department of Glaucoma, Anand Eye Institute, Hyderabad, Telangana, India.
出版信息
Indian J Ophthalmol. 2023 Jul;71(7):2919-2920. doi: 10.4103/ijo.IJO_445_22.
Abstract
摘要
相似文献
1
Secondary glaucoma after intravitreal dexamethasone implant in patients with retinal disorder.视网膜疾病患者玻璃体内植入地塞米松后发生的继发性青光眼。
Indian J Ophthalmol. 2023 Jul;71(7):2919-2920. doi: 10.4103/ijo.IJO_445_22.
2
Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.因视网膜中央静脉阻塞所致黄斑水肿而眼内注射地塞米松植入剂后出现的黄斑裂孔。
Acta Ophthalmol. 2013 Feb;91(1):e75-7. doi: 10.1111/j.1755-3768.2012.02484.x. Epub 2012 Aug 3.
3
Secondary glaucoma after intravitreal dexamethasone 0.7 mg implant in patients with retinal vein occlusion: a one-year follow-up.视网膜静脉阻塞患者玻璃体内注射 0.7mg 地塞米松后发生的继发性青光眼：一年随访。
J Ocul Pharmacol Ther. 2013 Jul-Aug;29(6):560-5. doi: 10.1089/jop.2012.0253. Epub 2013 Mar 12.
4
Accidental intralenticular dexamethasone intravitreal implant with the resolution of macular oedema in central retinal vein occlusion.意外眼内晶状体地塞米松玻璃体内植入与中心性视网膜静脉阻塞黄斑水肿的消退
Acta Ophthalmol. 2016 Dec;94(8):e810-e811. doi: 10.1111/aos.13062. Epub 2016 Apr 29.
5
Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.在未经治疗的视网膜静脉阻塞所致黄斑水肿患者中使用两个或更多地塞米松玻璃体内植入物：一项回顾性病历审查研究的亚组分析
BMC Ophthalmol. 2015 Sep 4;15:118. doi: 10.1186/s12886-015-0106-z.
6
Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report.玻璃体内注射地塞米松植入术后黄斑外视网膜裂孔：病例报告
Turk J Ophthalmol. 2019 Jun 27;49(3):175-177. doi: 10.4274/tjo.galenos.2019.98975.
7
OBSERVED COMPLICATIONS FROM DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA IN RETINAL VEIN OCCLUSION OVER 3 TREATMENT ROUNDS.在3个治疗周期内观察到地塞米松玻璃体内植入物治疗视网膜静脉阻塞性黄斑水肿的并发症。
Retina. 2015 Aug;35(8):1647-55. doi: 10.1097/IAE.0000000000000524.
8
Short-term safety of dexamethasone implant for treatment of macular edema due to retinal vein occlusion, in eyes with glaucoma or treated ocular hypertension.地塞米松植入物治疗青光眼或曾接受治疗的高眼压症患者视网膜静脉阻塞所致黄斑水肿的短期安全性。
Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):725-732. doi: 10.1007/s00417-016-3553-1. Epub 2016 Nov 22.
9
Anterior chamber bleeding due to intravitreal dexamethasone implant sclerotomy without vitreous hemorrhage.眼前房出血由于玻璃体内注射地塞米松植入物巩膜造口术而无玻璃体积血。
Eur J Ophthalmol. 2024 Jan;34(1):NP96-NP99. doi: 10.1177/11206721231178058. Epub 2023 May 30.
10
Safety of 6000 intravitreal dexamethasone implants.6000 枚玻璃体内植入型地塞米松安全性。
Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30.
本文引用的文献
1
Secondary glaucoma after intravitreal dexamethasone implant (Ozurdex) injection in patients with retinal disorder: A retrospective study.视网膜病变患者玻璃体内注射地塞米松植入剂（Ozurdex）后发生的继发性青光眼：一项回顾性研究。
Indian J Ophthalmol. 2022 Feb;70(2):585-589. doi: 10.4103/ijo.IJO_684_21.
2
Effect of central corneal thickness on intraocular pressure and comparison of Topcon CT-80 non-contact tonometry with Goldmann applanation tonometry.中央角膜厚度对眼压的影响以及拓普康CT-80非接触眼压计与戈德曼压平眼压计的比较。
Clin Exp Optom. 2018 Mar;101(2):206-212. doi: 10.1111/cxo.12620. Epub 2017 Oct 18.
Zotero 插件